EDIT vs SHOP · rev $32.3M vs P/E 107, rev $11.56B
Editas Medicine Inc (EDIT) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SHOP revenue for 2025-12-31 was $11.56B. Net income was $1.23B. Revenue was up 30.1% from 2024-12-31 to 2025-12-31. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
EDIT currently screens at market cap $375.2M. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the EDIT and SHOP stock pages for the full models.
Not investment advice.